C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor

Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
11/2011
11/29/2011	US8067569 Splice-region antisense composition and method
11/29/2011	US8067567 Modified tert promoter with enhanced tumor-specificity and strength and recombinant vector comprising the same
11/29/2011	US8067564 Methods of obtaining a specific binding member that binds eotaxin
11/29/2011	US8067563 Tumor suppressor gene, p471NG3
11/29/2011	US8067562 Isolated nucleic acid molecule comprising the amino acid sequence of SEQ ID NO:1
11/29/2011	US8067561 Isolated DNA encoding recombinant glucose isomerase
11/29/2011	US8067559 Yeast-based vaccines as immunotherapy
11/29/2011	US8067558 Constitutively active fragments of eukaryotic heat shock RNA
11/29/2011	US8067557 OCL-2A3 compositions and uses thereof
11/29/2011	US8067556 Multi-site mutagenesis
11/29/2011	US8067551 Combinatorial DNA library for producing modified N-glycans in lower eukaryotes
11/29/2011	US8067545 Isolated antibodies against biologically active leptin-related peptides
11/29/2011	US8067540 Human ALEX1 proteins
11/29/2011	US8067539 g-protein coupled receptor used in identifying modulators which improve palatability of low-calorie beverages through development of new artificial sweeteners; modulating taste perception
11/29/2011	US8067530 Scytovirin domain 1 related polypeptides
11/29/2011	US8067529 Immunogenic T-helper epitopes from human tumour antigens and immunotherapeutic methods using said epitopes
11/29/2011	US8067390 Therapeutic targeting of interleukins using siRNA in neutral liposomes
11/29/2011	US8067389 Silencing of TGFβ type II receptor expression by siRNA
11/29/2011	US8067388 Decoy-containing pharmaceutical compositions and method of using the same
11/29/2011	US8067385 Antiviral oligonucleotides targeting HBV
11/29/2011	US8067384 Chimera (double) decoy
11/29/2011	US8067383 Synthetic genes and genetic constructs comprising same I
11/29/2011	US8067377 Peptide compositions for targeting adipose tissue
11/29/2011	US8067341 Method for fabricating a biochip using the high density carbon nanotube film or pattern
11/29/2011	US8067339 Surface display of whole antibodies in eukaryotes
11/29/2011	US8067240 Methods for the diagnosis and treatment of lung cancer
11/29/2011	US8067239 Reagents for recombinogenic engineering and use thereof
11/29/2011	US8067234 Adipose stromal stem cells for tissue and vascular modification
11/29/2011	US8067229 Ucp4
11/29/2011	US8067228 Nucleic acid compositions and their use against the hepatitic C virus
11/29/2011	US8067227 Viral vectors and the use of the same for gene therapy
11/29/2011	US8067221 Von Willebrand factor (vWF)-cleaving protease
11/29/2011	US8067219 Polynucleotide encoding an ATP binding cassette transporter 1 (ABC1) polypeptide
11/29/2011	US8067210 Method of producing lysine by culturing a host cell expressing a polynucleotide encoding a feedback resistant aspartokinase from corynebacterium
11/29/2011	US8067206 for multiplex polymerase chain reactions (PCR) by the use of a volume excluding reagent in combination with a hot-start DNA polymerase; kits
11/29/2011	US8067205 Method of synthesizing cDNA
11/29/2011	US8067203 Composition for treating porcine progressive atrophic rhinitis and making process thereof
11/29/2011	US8067202 Bacterial superantigen vaccines
11/29/2011	US8067198 Protein expression system
11/29/2011	US8067197 Soluble recombinant αvβ3 adhesion receptor
11/29/2011	US8067196 Transferring sulfate on to 6-O position of n-acetylglucosamine sugar residue in polysaccharide preparation; anticoagulants and heparan sulfate activation; antithrombin
11/29/2011	US8067167 Hybrid antibodies
11/29/2011	US8067165 Binary probe and clamp composition and methods for target hybridization detection
11/29/2011	US8067157 Expression cloning in filamentous fungi
11/29/2011	US8067156 From adeno-associated virus; for treatment of acute conditions requiring rapid gene expression
11/29/2011	US8067016 Fusion proteins of Mycobacterium tuberculosis
11/29/2011	US8067014 Chimeric AAV capsid proteins
11/29/2011	US8067012 Treatment of melanoma using HSV mutant
11/29/2011	US8067010 Immunological herpes simplex virus antigens and methods for use thereof
11/29/2011	US8067007 Compositions and methods for identifying and targeting cancer cells of alimentary canal origin
11/29/2011	US8067004 Surface antigen
11/29/2011	US8067001 Antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof
11/29/2011	US8066994 Proteins comprising an IgG2 domain
11/29/2011	US8066985 Reovirus for the treatment of cellular proliferative disorders
11/29/2011	US8066984 Modified vaccinia virus strains for use in diagnostic and therapeutic methods
11/29/2011	US8066978 Biopolymer and gene complex
11/29/2011	US8066972 Altering memory by affecting staufen function
11/29/2011	CA2593427C Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood glp-1 level
11/29/2011	CA2525657C Human monoclonal antibody specific for lipopolysaccharides (lps) of serotype iats o6 of pseudomonas aeruginosa
11/29/2011	CA2499084C Actn3 genotype screen for athletic performance
11/29/2011	CA2490098C Plant defensins
11/29/2011	CA2484166C Improved chimeric glycoproteins and pseudotyped lentiviral vectors
11/29/2011	CA2440461C Nucleic acid and corresponding protein entitled 161p5c5 useful in treatment and detection of cancer
11/29/2011	CA2414331C Pd-l2 molecules: novel pd-1 ligands and uses therefor
11/29/2011	CA2401438C Novel human ulip/crmp protein and use thereof in diagnosis and treatment of cancers and paraneoplastic neurological syndromes
11/29/2011	CA2378615C Modified cytochrome p450 monooxygenases
11/29/2011	CA2377567C High throughput assay system
11/29/2011	CA2366541C Novel recombinant and mutant herpesviruses
11/29/2011	CA2346931C Gene delivery system and methods of use
11/29/2011	CA2344764C Intein mediated peptide ligation
11/29/2011	CA2342199C Monoclonal antibodies against s100
11/29/2011	CA2315776C High throughput assay system
11/29/2011	CA2293632C Artificial antibody polypeptides
11/29/2011	CA2292768C Fatty acyl-coa: fatty alcohol acyltransferases
11/29/2011	CA2233447C Mimicking peptides in cancer therapy
11/29/2011	CA2200202C Production of hydroxylated fatty acids in genetically modified plants
11/25/2011	CA2762837A1 Synthetic polypeptide libraries and methods for generating naturally diversified polypeptide variants
11/24/2011	WO2011146938A1 Reagents and methods for treating cancer
11/24/2011	WO2011146902A1 Bi-specific fusion proteins
11/24/2011	WO2011146833A1 Method of producing isoprenoid compounds in yeast
11/24/2011	WO2011146754A1 Altered leaf morphology and enhanced agronomic properties in plants
11/24/2011	WO2011146524A1 Production of dha and other lc-pufas in plants
11/24/2011	WO2011146405A1 Egf +61g/a and ts 5'utr 2r/3r polymorphisms predict clinical outcomes in cancer patients undergoing anti-egfr therapy
11/24/2011	WO2011145795A1 Cartilage-specific hif-2α transgenic mouse as an animal model for arthritis, and use thereof
11/24/2011	WO2011145772A1 Method for detecting cancer events-regulating gene in ionizing radiation-irradiated mice, and gene group
11/24/2011	WO2011145744A1 Anti-human trop-2 antibody having antitumor activity in vivo
11/24/2011	WO2011145725A1 Method and kit for diagnosing aim-related illness
11/24/2011	WO2011145629A2 ANTIBODY CAPABLE OF BINDING TO TRANSFORMING GROWTH FACTOR ALPHA AND HAVING ANTIPROLIFERATIVE ACTIVITY ON CANCER HAVING Ras GENE MUTATION
11/24/2011	WO2011145615A1 Nucleic acid for production of pluripotent stem cell
11/24/2011	WO2011145614A1 Method for designing probe for detecting nucleic acid reference material, probe for detecting nucleic acid reference material, and nucleic acid detection system having probe for detecting nucleic acid reference material
11/24/2011	WO2011145211A1 Ketoreductase mutant
11/24/2011	WO2011145081A1 Influenza virus reassortment method
11/24/2011	WO2011145015A1 Plants having increased tolerance to herbicides
11/24/2011	WO2011145013A1 Parapoxvirus vectors containing rabies virus antigen
11/24/2011	WO2011144953A1 Procedure for producing recombinant human tissue factor
11/24/2011	WO2011144892A1 Cationic lipids
11/24/2011	WO2011144784A1 Lacasse with high redox potential
11/24/2011	WO2011144761A1 Compositions for use in treating or diagnosing bone disorders and/or cardiovascular disorders
11/24/2011	WO2011144416A1 Control material for nucleic acid tests
11/24/2011	WO2011144360A1 Marker vaccine for classical swine fever

1 ... 666 667 668 669 670 671 672 673 674 675 676 677 678 679 680 681 682 683 684 685 686 ... 4023